- Report
- January 2026
- 181 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- March 2025
- 175 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- October 2025
- 160 Pages
Global
From €3449EUR$3,950USD£2,986GBP
- Report
- August 2025
- 154 Pages
Global
From €2532EUR$2,900USD£2,192GBP
- Report
- July 2025
- 150 Pages
Global
From €5195EUR$5,950USD£4,498GBP
- Report
- January 2026
- 181 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 199 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- November 2025
- 188 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 182 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 186 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 196 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 182 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 199 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 186 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 270 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 340 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1091EUR$1,250USD£945GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1091EUR$1,250USD£945GBP
- Report
- January 2026
- 180 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- January 2026
- 130 Pages
Global
From €4147EUR$4,750USD£3,591GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more